title: [Should beta blockers remain as first-line therapy in the treatment of patients with atrial fibrillation and heart failure?].
authors.affiliation: Servicio de Cardiología, Hospital Universitario La Paz, Madrid, España; Grupo de Hipertensión Arterial de SEMERGEN. Electronic address: escobar_cervantes_carlos@hotmail.com.
authors.forename: C
authors.initials: C
authors.lastname: Escobar
authors.affiliation: Facultad de Medicina, Universidad Católica San Antonio de Murcia (UCAM), Murcia, España; Grupo de Hipertensión Arterial de SEMERGEN.
authors.forename: J A
authors.initials: JA
authors.lastname: Divisón
mesh_terms: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002318:Cardiovascular Diseases; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents